HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Inhibition of hepatic drug metabolism in VX2 carcinoma-bearing rabbits.

Abstract
Hepatic metabolism of aniline, p-chloro-N-methylaniline, and aminopyrine was determined in control male, New Zealand White rabbits or those bearing VX2 carcinoma (a prostaglandin-secreting tumor). In addition, the levels of cyclic AMP and cyclic GMP in the liver and the concentration of calcium in serum were examined. After 13 days of tumor growth, metabolism of aminopyrine and PCMA was decreased by approximately 30%, whereas aniline metabolism was not significantly altered. Metabolism of all substrates was significantly depressed to 20-60% of control by 22 days after transplantation. Serum calcium levels increased by 14 and 29% after 13 and 22 days, respectively. The ratio of cyclic AMP to cyclic GMP was 156% of control after 13 days and 139% by 22 days of tumor growth. The increased ratio was due solely to a change in cyclic AMP concentration. A 20-min pretreatment with prostaglandin E1, 0.3 mg/kg ip, depressed in vitro hepatic metabolism of all substrates by 27-56% while increasing cyclic AMP levels by 42%.
AuthorsM Weiner, J W Olson
JournalDrug metabolism and disposition: the biological fate of chemicals (Drug Metab Dispos) 1980 May-Jun Vol. 8 Issue 3 Pg. 139-42 ISSN: 0090-9556 [Print] UNITED STATES
PMID6104575 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Aniline Compounds
  • Prostaglandins E
  • Aminopyrine
  • 4-chloro-N-methylaniline
  • Cyclic AMP
  • Cyclic GMP
  • Calcium
Topics
  • Aminopyrine (metabolism)
  • Aniline Compounds (metabolism)
  • Animals
  • Calcium (blood)
  • Carcinoma, Squamous Cell (metabolism)
  • Cyclic AMP (metabolism)
  • Cyclic GMP (metabolism)
  • Kinetics
  • Liver (metabolism)
  • Male
  • Microsomes, Liver (metabolism)
  • Neoplasm Transplantation
  • Neoplasms, Experimental (metabolism)
  • Prostaglandins E (metabolism)
  • Rabbits
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: